CVE-2023-33861
MEDIUMCVSS 6.5/10EPSS 0.20%
Last modified
CVE-2023-33861 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.. EPSS estimates a 0.20% chance of exploitation in the next 30 days.
Description
IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Security Qradar Edr | >= 3.12, < 3.12.17 |
References
- https://www.ibm.com/support/pages/node/7233972Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Analyzed
Frequently Asked Questions
What is CVE-2023-33861?
IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.
How severe is CVE-2023-33861?
CVE-2023-33861 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.20% probability of exploitation in the next 30 days.
How do I fix CVE-2023-33861?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-33861?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST